Tag: MD

Sessions

OBSERVATIONAL STUDIES ARE IN THE EYE OF THE BEHOLDER

There is a critical gap in evidence regarding whether different treatment strategies early in relapsing multiple sclerosis prevent...

Read More

Sessions

THE WHOLE HEALTH MODEL: PARADIGM SHIFT IN MS CARE

Medicine is moving from a model that is largely based on outpatient office-based providers and referrals to outside health professionals...

Read More

Sessions

FUNDAMENTALS OF MS CARE – PART 1: DIAGNOSING THE DISEASE AND MANAGING SPECIFIC POPULATIONS

Sessions 1 and 2 of Fundamentals offers a multidisciplinary approach in the diagnosis and management of multiple sclerosis (MS). The...

Read More

Sessions

FUNDAMENTALS OF MS CARE – PART 2: DIAGNOSING THE DISEASE AND MANAGING SPECIFIC POPULATIONS

Sessions 1 and 2 of Fundamentals offers a multidisciplinary approach in the diagnosis and management of multiple sclerosis (MS). The...

Read More

Sessions

RECOVERY AND REPAIR: REMYELINATION AND CLINICAL TRIALS

The treatment of multiple sclerosis (MS) has been transformed by the successful development of immunotherapies that efficiently reduce...

Read More

Sessions

MULTIPLE SCLEROSIS AND DEPRESSION

The aim of the symposium is to provide a comprehensive overview of depression in people with MS. Clinicians and researchers are faced with...

Read More

Sessions

JOHN F. KURTZKE MEMORIAL LECTURE: UPDATE ON PROGRESSIVE MS

Over the past two and half decades, an increasing number therapies have become available to treat relapsing forms of multiple sclerosis....

Read More

Sessions

MRI INTERNATIONAL GUIDELINES

MRI is an invaluable tool for establishing an early diagnosis of MS and for monitoring patients’ disease course and response to treatment....

Read More

Sessions

TELENEUROLOGY AND DIGITAL PHENOTYPING IN MULTIPLE SCLEROSIS

Access to care for people living with MS often leaves gaps in expertise related to diagnosis, treatment decisions and follow-up of symptoms...

Read More

Sessions

WHITAKER LECTURE: PRECISION NEUROIMMUNOLOGY IN MULTIPLE SCLEROSIS – ARE WE THERE YET?

Among the major unmet needs in the MS field is defining the biological mechanisms that underlie patient heterogeneity – whether...

Read More